Alnylam Pharmaceuticals Inc (ALNY) — Defensive Interval Ratio
Alnylam Pharmaceuticals Inc (ALNY) has a Defensive Interval Ratio of 505 days as of December 2025. Defensive assets of $2.03 Billion (cash $-, short-term investments $1.25 Billion, receivables $777.57 Million) cover 505 days of daily cash needs of $4.02 Million/day. For the complete balance sheet picture, see ALNY current and non-current assets.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Alnylam Pharmaceuticals Inc Defensive Interval Ratio (2002–2025)
This chart shows how Alnylam Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 505 days, meaning defensive assets of $2.03 Billion can fund 505 days of operations without new revenue. Check Alnylam Pharmaceuticals Inc (ALNY) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Annual Defensive Interval Ratio for Alnylam Pharmaceuticals Inc (2002–2025)
The table below presents the year-by-year Defensive Interval Ratio for Alnylam Pharmaceuticals Inc from 2002 to 2025, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 505 days | $2.03 Billion | $4.02 Million/day | $- | $1.25 Billion | ▼ -151 days |
| 2024 | 656 days | $2.13 Billion | $3.25 Million/day | $- | $1.73 Billion | ▼ -81 days |
| 2023 | 737 days | $1.95 Billion | $2.65 Million/day | $- | $1.63 Billion | ▼ -6 days |
| 2022 | 743 days | $1.56 Billion | $2.10 Million/day | $- | $1.33 Billion | ▼ -208 days |
| 2021 | 952 days | $1.81 Billion | $1.91 Million/day | $- | $1.62 Billion | ▼ -283 days |
| 2020 | 1235 days | $1.98 Billion | $1.60 Million/day | $- | $1.38 Billion | ▲ +167 days |
| 2019 | 1068 days | $1.03 Billion | $966.01K/day | $- | $988.98 Million | ▲ +42 days |
| 2018 | 1026 days | $682.77 Million | $665.31K/day | $- | $664.01 Million | ▼ -960 days |
| 2017 | 1987 days | $1.08 Billion | $543.28K/day | $- | $1.05 Billion | ▲ +1121 days |
| 2016 | 865 days | $456.52 Million | $527.64K/day | $- | $433.18 Million | ▼ -4471 days |
| 2015 | 5337 days | $907.93 Million | $170.13K/day | $- | $899.64 Million | ▲ +2804 days |
| 2014 | 2532 days | $661.45 Million | $261.19K/day | $- | $621.51 Million | ▲ +1198 days |
| 2013 | 1335 days | $196.95 Million | $147.57K/day | $- | $192.70 Million | ▲ +795 days |
| 2012 | 540 days | $71.51 Million | $132.45K/day | $- | $71.41 Million | ▼ -1022 days |
| 2011 | 1562 days | $77.64 Million | $49.70K/day | $- | $76.17 Million | ▲ +1290 days |
| 2010 | 272 days | $172.65 Million | $634.35K/day | $- | $158.53 Million | ▼ -222 days |
| 2009 | 494 days | $149.98 Million | $303.38K/day | $- | $143.93 Million | ▼ -397 days |
| 2008 | 891 days | $242.78 Million | $272.47K/day | $- | $238.60 Million | ▼ -376 days |
| 2007 | 1267 days | $289.82 Million | $228.71K/day | $- | $284.79 Million | ▼ -216 days |
| 2006 | 1483 days | $93.13 Million | $62.81K/day | $- | $89.31 Million | ▲ +199 days |
| 2005 | 1284 days | $65.00 Million | $50.64K/day | $- | $64.25 Million | ▼ -212 days |
| 2004 | 1496 days | $26.94 Million | $18.01K/day | $- | $25.77 Million | ▲ +1460 days |
| 2003 | 35 days | $373.00K | $10.53K/day | $- | $373.00K | ▲ +33 days |
| 2002 | 3 days | $19.00K | $7.32K/day | $- | $19.00K | — |